Applicability and cost-effectiveness of the Systolic Blood Pressure Intervention Trial (SPRINT) in the Chinese population: A cost-effectiveness modeling study

by Chao Li, Kangyu Chen, Victoria Cornelius, Ewan Tomeny, Yang Wang, Xiaowei Yang, Xiaodan Yuan, Rui Qin, Dahai Yu, Zhenqiang Wu, Duolao Wang, Tao Chen BackgroundThe Systolic Blood Pressure Intervention Trial (SPRINT) showed significant reductions in death and cardiovascular disease (CVD) risk with a systolic blood pressure (SBP) goal of

http://feedproxy.google.com/~r/plosmedicine/NewArticles/~3/2ROChKMLe6U/article

Source: PLoS Medicine - March 4, 2021 Category: Internal Medicine Authors: Chao Li Source Type: research